PRICE T ROWE ASSOCIATES INC /MD/ - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$31,000
-48.3%
70,4000.0%0.00%–
Q2 2022$60,000
-98.9%
70,400
-92.9%
0.00%
-100.0%
Q1 2022$5,425,000
-39.7%
984,646
+5.9%
0.00%0.0%
Q4 2021$9,004,000–930,179–0.00%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders